Wenge Huang

828 total citations
33 papers, 658 citations indexed

About

Wenge Huang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Wenge Huang has authored 33 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Wenge Huang's work include Pharmacological Effects of Natural Compounds (5 papers), Berberine and alkaloids research (4 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Wenge Huang is often cited by papers focused on Pharmacological Effects of Natural Compounds (5 papers), Berberine and alkaloids research (4 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Wenge Huang collaborates with scholars based in China and Australia. Wenge Huang's co-authors include Fengying Chen, Heqing Huang, Ping Wang, Weihua Liu, Xianli Meng, Xiang Li, Yingfan Hu, Jiasi Wu, Peiqing Liu and Xuejuan Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Archives of Biochemistry and Biophysics.

In The Last Decade

Wenge Huang

32 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenge Huang China 14 267 173 137 96 91 33 658
Dong Ho Jung South Korea 16 236 0.9× 79 0.5× 77 0.6× 75 0.8× 90 1.0× 48 746
Kyuhyung Jo South Korea 18 308 1.2× 93 0.5× 65 0.5× 80 0.8× 101 1.1× 56 1.0k
Mamdouh M. El‐Shishtawy Egypt 20 391 1.5× 61 0.4× 145 1.1× 87 0.9× 54 0.6× 49 1.1k
Yiyi Jin China 16 353 1.3× 98 0.6× 66 0.5× 108 1.1× 71 0.8× 31 747
Yiqi Yang China 15 424 1.6× 204 1.2× 98 0.7× 91 0.9× 171 1.9× 30 841
Chun-Feng Zhang China 16 363 1.4× 106 0.6× 134 1.0× 56 0.6× 142 1.6× 30 720
Ke Pan China 18 316 1.2× 179 1.0× 69 0.5× 132 1.4× 169 1.9× 73 936
Baoqin Lin China 17 320 1.2× 87 0.5× 108 0.8× 54 0.6× 122 1.3× 31 676
Lieqiang Xu China 16 373 1.4× 95 0.5× 189 1.4× 36 0.4× 79 0.9× 23 797
Yong‐Yu Yang China 15 456 1.7× 63 0.4× 155 1.1× 60 0.6× 40 0.4× 31 817

Countries citing papers authored by Wenge Huang

Since Specialization
Citations

This map shows the geographic impact of Wenge Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenge Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenge Huang more than expected).

Fields of papers citing papers by Wenge Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenge Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenge Huang. The network helps show where Wenge Huang may publish in the future.

Co-authorship network of co-authors of Wenge Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenge Huang. A scholar is included among the top collaborators of Wenge Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenge Huang. Wenge Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Wen, Dongsheng, Chen Wang, Wenge Huang, et al.. (2024). Betaine delays age‐related muscle loss by mitigating Mss51‐induced impairment in mitochondrial respiration via Yin Yang1. Journal of Cachexia Sarcopenia and Muscle. 15(5). 2104–2117. 6 indexed citations
4.
Wang, Chen, Wenge Huang, Zhijun Yang, et al.. (2024). Choline suppresses hepatocellular carcinoma progression by attenuating AMPK/mTOR-mediated autophagy via choline transporter SLC5A7 activation. HepatoBiliary Surgery and Nutrition. 13(3). 393–411. 7 indexed citations
5.
Yang, Zhijun, Siyu Huang, Wenge Huang, et al.. (2024). Betaine alleviates cognitive impairment induced by homocysteine through attenuating NLRP3-mediated microglial pyroptosis in an m6A-YTHDF2-dependent manner. Redox Biology. 69. 103026–103026. 36 indexed citations
6.
Wang, Chen, et al.. (2023). Betaine attenuates age-related suppression in autophagy via Mettl21c/p97/VCP axis to delay muscle loss. The Journal of Nutritional Biochemistry. 125. 109555–109555. 6 indexed citations
7.
Tian, Ruimin, Wenge Huang, Tao Zhang, et al.. (2022). Hezi inhibits Tiebangchui-induced cardiotoxicity and preserves its anti-rheumatoid arthritis effects by regulating the pharmacokinetics of aconitine and deoxyaconitine. Journal of Ethnopharmacology. 302(Pt A). 115915–115915. 9 indexed citations
8.
Wen, Wen, et al.. (2021). Benzaldehyde, A New Absorption Promoter, Accelerating Absorption on Low Bioavailability Drugs Through Membrane Permeability. Frontiers in Pharmacology. 12. 663743–663743. 12 indexed citations
9.
Chen, Huan, et al.. (2020). Inhibition of eIF2α Dephosphorylation Protects Hepatocytes from Apoptosis by Alleviating ER Stress in Acute Liver Injury. BioMed Research International. 2020(1). 2626090–2626090. 6 indexed citations
10.
Luo, Yu, Qing Jiang, Jiasi Wu, et al.. (2020). Phosphoproteomics and Proteomics Reveal Metabolism as a Key Node in LPS-Induced Acute Inflammation in RAW264.7. Inflammation. 43(5). 1667–1679. 15 indexed citations
11.
Wu, Jiasi, Yu Luo, Qing Jiang, et al.. (2019). Coptisine from Coptis chinensis blocks NLRP3 inflammasome activation by inhibiting caspase-1. Pharmacological Research. 147. 104348–104348. 79 indexed citations
12.
Hu, Yingfan, Li Wang, Xiang Li, et al.. (2019). Pharmacokinetic-Pharmacodynamic Modeling for Coptisine Challenge of Inflammation in LPS-Stimulated Rats. Scientific Reports. 9(1). 1450–1450. 19 indexed citations
13.
Chen, Guimei, Yi-Huai He, Wenge Huang, et al.. (2019). Inhibiting alpha subunit of eukaryotic initiation factor 2 dephosphorylation protects injured hepatocytes and reduces hepatocyte proliferation in acute liver injury. Croatian Medical Journal. 60(6). 532–544. 4 indexed citations
14.
Li, Xiang, Yingfan Hu, Jiasi Wu, et al.. (2018). Semi-Mechanism-Based Pharmacodynamic Model for the Anti-Inflammatory Effect of Baicalein in LPS-Stimulated RAW264.7 Macrophages. Frontiers in Pharmacology. 9. 793–793. 21 indexed citations
15.
Wu, Jiasi, Yingfan Hu, Xiang Li, et al.. (2016). San-Huang-Xie-Xin-Tang Constituents Exert Drug-Drug Interaction of Mutual Reinforcement at Both Pharmacodynamics and Pharmacokinetic Level: A Review. Frontiers in Pharmacology. 7. 448–448. 22 indexed citations
16.
Li, Yang, Yanfeng Wu, Xiaoping Wang, et al.. (2011). Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice. Annals of Hematology. 90(8). 873–885. 21 indexed citations
17.
Liu, Weihua, Ziqing Hei, Hong Nie, et al.. (2008). Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chinese Medical Journal. 121(8). 706–712. 99 indexed citations
18.
Liu, Weihua, Sha Tao, Yanhui Deng, et al.. (2008). Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose. Archives of Biochemistry and Biophysics. 475(2). 128–134. 80 indexed citations
19.
Hei, Ziqing, Peiqing Liu, Lingzhi Zhao, et al.. (2006). Emodin inhibits dietary induced atherosclerosis by antioxidation and regulation of the sphingomyelin pathway in rabbits. Chinese Medical Journal. 119(10). 868–870. 19 indexed citations
20.
Wang, Jinping, Heqing Huang, Peiqing Liu, et al.. (2006). Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats. European Journal of Pharmacology. 553(1-3). 297–303. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026